AUREX GRUPO SAN PABLO
⚠️ High Risk
FEI: 3031802183 • Mexico City • MEXICO
FEI Number
3031802183
Location
Mexico City
Country
MEXICOAddress
Benito Juarez Napoles F, , Mexico City, , Mexico
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/8/2024 | 56BDY03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/8/2024 | 56KCY10CHLORAMPHENICOL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/8/2024 | 65NDY17CYANOCOBALAMIN CO 60 (RADIOACTIVE AGENT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/8/2024 | 61WCY45FLUCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/8/2024 | 56JCY31CLINDAMYCIN PHOSPHATE (LINCOMYCINS) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is AUREX GRUPO SAN PABLO's FDA import refusal history?
AUREX GRUPO SAN PABLO (FEI: 3031802183) has 5 FDA import refusal record(s) in our database, spanning from 10/8/2024 to 10/8/2024.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. AUREX GRUPO SAN PABLO's FEI number is 3031802183.
What types of violations has AUREX GRUPO SAN PABLO received?
AUREX GRUPO SAN PABLO has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about AUREX GRUPO SAN PABLO come from?
All FDA import refusal data for AUREX GRUPO SAN PABLO is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.